CASI Pharmaceuticals (CASI) Other Gross PP&E Adjustments (2021 - 2025)
Historic Other Gross PP&E Adjustments for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to -$3.0 million.
- Pharmaceuticals' Other Gross PP&E Adjustments rose 9982.64% to -$3.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$3.0 million, marking a year-over-year increase of 9982.64%. This contributed to the annual value of $4.1 million for FY2024, which is 10017.38% up from last year.
- As of Q2 2025, Pharmaceuticals' Other Gross PP&E Adjustments stood at -$3.0 million, which was up 9982.64% from -$3.3 billion recorded in Q1 2025.
- Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $4.1 million for Q4 2024, and its period low was -$3.3 billion during Q1 2025.
- For the 5-year period, Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$975.9 million, with its median value being -$11.6 million (2021).
- In the last 5 years, Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 10513.73% in 2022 and then tumbled by 40089394.96% in 2023.
- Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$11.6 million in 2021, then surged by 105.14% to $595000.0 in 2022, then crashed by 400893.95% to -$2.4 billion in 2023, then surged by 100.17% to $4.1 million in 2024, then plummeted by 173.55% to -$3.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$3.0 million for Q2 2025, versus -$3.3 billion for Q1 2025 and $4.1 million for Q4 2024.